News

Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®

-- First patients have purchased PoNS devices to initiate PoNS Therapy ---- Nineteen PoNS device prescriptions have been written in…

2 years ago

Carisk Partners’ Alana Letourneau, MD, MBA Named a 2022 Rising Insurance Star Executive Award Winner

MIAMI--(BUSINESS WIRE)--Carisk Partners (Carisk), a specialty risk transfer and care coordination company, is pleased to announce that that Alana Letourneau,…

2 years ago

Sonendo, Inc. To Showcase Newly Launched CleanFlow™ Technology at 2022 AAE Annual Meeting

Located at Booth #1013, Sonendo Will Provide a First Look at the New CleanFlow Procedure Instrument, Offer Hands-on Test Drives…

2 years ago

Azalea Health and Phreesia Partner to Offer an Integrated Intake Experience to Growing Network of Providers

ATLANTA & RALEIGH, N.C.--(BUSINESS WIRE)--Azalea Health, a leading provider of cloud-based patient management and health IT solutions, and Phreesia, a…

2 years ago

XVIVO Submits an IDE Application to US FDA for Its Innovative Heart Technology – a Significant Milestone

GOTHENBURG, SE / ACCESSWIRE / April 27, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO proudly announces the filing of an Investigational…

2 years ago

Spago Nanomedical Interim Report January-March 2022

LUND, SE / ACCESSWIRE / April 27, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Several important milestones in the first quarterJANUARI - MARCH…

2 years ago

Spexis Annual General Meeting 2022

Ad hoc announcement pursuant to Art. 53 LRALLSCHWIL, SWITZERLAND / ACCESSWIRE / April 27, 2022 / Spexis AG (SIX:SPEX) today…

2 years ago

Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R)

Notice of Allowance of Patent Application for Modified Release Orally Administered Amino Acid Formulations, Strengthens Proprietary Position in U.S. until…

2 years ago

Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering

SAN MATEO, CA / ACCESSWIRE / April 26, 2022 / Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON) (NASDAQ:ACONW), a healthcare…

2 years ago

NLS Pharmaceutics Ltd. Announces Closing of US$4.4 Million Registered Direct Offering

ZURICH, SWITZERLAND / ACCESSWIRE / April 26, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) (NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss…

2 years ago